-
Story /A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.
-
Story /Ambitious scientist accelerates research into African genomic diversity and health challenges with internship
-
Story /Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.
-
Story /Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
-
Story /The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story /Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.
-
Story /Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.
-
Story / -
Story /Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.
Pagination
- ‹ Previous page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- …
- 288
- › Next page